Bilirubin / Albumin Ratio

The Bilirubin-to-Albumin Ratio (B/A ratio) measures the relationship between two key liver-related markers: bilirubin, a yellow pigment formed when red blood cells break down, and albumin, a protein made by the liver that helps maintain fluid balance and transport hormones, nutrients, and waste products.

The ratio is calculated by dividing total bilirubin by albumin levels in the blood. Together, these markers provide a snapshot of how efficiently the liver is functioning — both in breaking down and clearing waste and in producing vital proteins.

The B/A ratio is one of the most useful ways to evaluate overall liver function and detect early signs of metabolic or systemic stress. When bilirubin builds up, it can indicate that the liver is struggling to process toxins or that red blood cell turnover is increased. At the same time, a drop in albumin suggests reduced liver protein synthesis or inflammation.

Elevated B/A ratios are linked to worse outcomes in conditions such as hepatic encephalopathy, alcoholic hepatitis, and cirrhosis. Studies show that a higher ratio predicts increased mortality risk in critically ill patients and those with combined liver and kidney impairment.

Even outside severe disease, subtle changes in this ratio can reflect nutritional deficits, chronic inflammation, or early liver stress, making it a valuable biomarker for long-term health tracking.

 The B/A ratio can shift for a range of reasons, from diet and lifestyle to serious medical conditions:

• Liver Function: When the liver is inflamed, fatty, or scarred (as in fatty liver disease, hepatitis, or cirrhosis), bilirubin levels rise while albumin production drops, raising the ratio.
  

• Kidney Health: Impaired kidney function reduces bilirubin clearance and protein filtration, impacting both components of the ratio.
  

• Nutrition and Protein Intake: Low dietary protein or malnutrition lowers albumin synthesis, which can falsely elevate the ratio even without major liver disease.
  

• Inflammation and Infection: Systemic inflammation reduces albumin production and can mildly elevate bilirubin through oxidative stress.
  

• Alcohol and Medications: Excess alcohol, acetaminophen, and certain drugs can impair bilirubin metabolism or suppress albumin synthesis, increasing the ratio.
  

• Because both bilirubin and albumin are dynamic, the ratio can change with hydration, diet, and recovery from illness — making trends over time more meaningful than a single measurement.

If High:
A high B/A ratio indicates liver strain, protein deficiency, or systemic inflammation.

• Support Liver Function: Minimise alcohol and avoid hepatotoxic medications unless prescribed. Incorporate liver-supportive nutrients such as B vitamins, choline, and antioxidants from leafy greens, cruciferous vegetables, and citrus.
  

• Prioritise Protein: Ensure adequate daily protein intake from clean sources like fish, eggs, legumes, and lean meats to boost albumin synthesis.
  

• Hydrate and Move: Staying well-hydrated and engaging in regular movement supports kidney function and bilirubin clearance.
  

• Medical Evaluation: Persistent elevation may require medical work-up, including liver enzyme testing (ALT, AST, ALP, GGT), imaging, or assessment for hepatitis, fatty liver, or alcohol-related damage.
  

If Low:
A low B/A ratio is generally less concerning, though it may indicate dehydration or overhydration, or reflect rapid red blood cell turnover in recovery.

• Maintain Hydration: Keep fluids balanced and avoid excessive diuretic use.
  

• Monitor Nutrition: Support recovery with nutrient-dense foods and balanced electrolytes to maintain stable albumin and bilirubin levels.

1. Li Y, Liu H, Chen K, et al. Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy. Frontiers in Medicine. 2021;8:706407. doi:10.3389/fmed.2021.706407.
   

2. Das S, Maras JS, Maiwall R, et al. Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology. 2018;16(8):1322–1332.e4. doi:10.1016/j.cgh.2017.11.022.
   

3. Huang X, Huang Y, Chen M, Liao L, Lin F. Association Between Total Bilirubin/Albumin Ratio and All-Cause Mortality in Acute Kidney Injury Patients: A Retrospective Cohort Study. PloS One. 2023;18(11):e0287485. doi:10.1371/journal.pone.0287485.
   

4. Yang X, Wang G, Min Z, Lv L, Yang J. The Prognostic Value of the Direct Bilirubin to Albumin Ratio in Critically Ill Patients With Cirrhosis: Insights From MIMIC-IV Database.PloS One. 2025;20(10):e0334591. doi:10.1371/journal.pone.0334591.